We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$419M
AUM Growth
+$56.7M
Cap. Flow
+$128M
Cap. Flow %
30.67%
Top 10 Hldgs %
66.93%
Holding
92
New
53
Increased
2
Reduced
10
Closed
24

Top Buys

Rank Stock Value
1
GPCR icon
Structure Therapeutics
GPCR
+$33.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$9.43M
3
RDNT icon
RadNet
RDNT
+$8.72M
4
CWST icon
Casella Waste Systems
CWST
+$7.58M
5
NXT icon
Nextpower Inc
NXT
+$7.34M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$16.9M
2
ALIT icon
Alight
ALIT
+$6.95M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$5.18M
4
VKTX icon
Viking Therapeutics
VKTX
+$5M
5
RCL icon
Royal Caribbean
RCL
+$4.24M

Sector Composition

Rank Sector Weight
1 Healthcare 20.13%
2 Technology 3.56%
3 Industrials 3.21%
4 Consumer Discretionary 2.78%
5 Real Estate 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLGC
26
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$1.85M 0.44%
799,784
-190,077
-19% -$537K
ANTX icon
27
AN2 Therapeutics
ANTX
$214M
$1.55M 0.37%
181,995
-65,472
-26% -$471K
ALIT icon
28
Alight
ALIT
$407M
$1.54M 0.37%
8,314
-39,186
-82% -$6.95M
SKWD icon
29
Skyward Specialty Insurance
SKWD
$2.58B
$1.52M 0.36%
+59,861
New +$1.38M
BLBD icon
30
Blue Bird Corp
BLBD
$2.18B
$1.46M 0.35%
+65,000
New +$1.39M
OSW icon
31
OneSpaWorld
OSW
$2.66B
$1.45M 0.35%
+120,000
New +$1.39M
SEAT icon
32
Vivid Seats
SEAT
$85.4M
$1.38M 0.33%
+8,705
New +$1.36M
GH icon
33
Guardant Health
GH
$22.6B
$1.32M 0.32%
+37,000
New +$1.06M
AESI icon
34
Atlas Energy Solutions
AESI
$1.41B
$1.3M 0.31%
75,000
-125,000
-63% -$2.18M
KLRS
35
Kalaris Therapeutics
KLRS
$96.8M
$1.27M 0.3%
+16,304
New +$1.55M
KURA icon
36
Kura Oncology
KURA
$850M
$1.27M 0.3%
+120,000
New +$1.42M
BHVN icon
37
Biohaven
BHVN
$2.21B
$1.2M 0.29%
50,000
-200,000
-80% -$3.44M
NAMS icon
38
NewAmsterdam Pharma
NAMS
$3.34B
$1.13M 0.27%
+95,000
New +$1.26M
XFOR icon
39
X4 Pharmaceuticals
XFOR
$460M
$1.11M 0.27%
+19,093
New +$981K
STER
40
DELISTED
Sterling Check Corp. Common Stock
STER
$1.1M 0.26%
+89,529
New +$1.07M
TCRX icon
41
TScan Therapeutics
TCRX
$52M
$1M 0.24%
+400,000
New +$1.07M
ENLT icon
42
Enlight Renewable Energy
ENLT
$11.9B
$892K 0.21%
50,263
-43,920
-47% -$777K
BDTX icon
43
Black Diamond Therapeutics
BDTX
$112M
$859K 0.2%
+170,000
New +$347K
WKC icon
44
World Kinect Corp
WKC
$1.86B
$827K 0.2%
+40,000
New +$953K
KGS icon
45
Kodiak Gas Services
KGS
$6.05B
$624K 0.15%
+38,400
New +$613K
SVV icon
46
Savers
SVV
$1.88B
$593K 0.14%
+25,000
New +$583K
COGT icon
47
Cogent Biosciences
COGT
$7.24B
$592K 0.14%
+50,000
New +$574K
CDTX
48
DELISTED
Cidara Therapeutics
CDTX
$417K 0.1%
18,455
– –
MSGE icon
49
Madison Square Garden
MSGE
$3.62B
$336K 0.08%
+10,000
New +$343K
CAVA icon
50
CAVA Group
CAVA
$7.27B
$205K 0.05%
+5,000
New +$206K
1
2
3

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Monashee Investment Management held 92 positions worth $419M, up 16% from $362M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Monashee Investment Management deployed $128M of net new capital in Q2 2023, opening 53 new positions and adding to 2 existing holdings. Its largest new stake was RadNet: 300,000 shares worth $9.79M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Alight, an estimated $6.95M trimmed.

  • Monashee Investment Management's largest Q2 2023 buy was RadNet: 300,000 shares worth $9.79M.
  • Monashee Investment Management added most to Structure Therapeutics in Q2 2023, an estimated $33.7M increase.
  • Monashee Investment Management's biggest Q2 2023 reduction was Alight, cutting an estimated $6.95M.
  • Monashee Investment Management fully exited iShares Russell 2000 ETF in Q2 2023, selling an estimated $16.9M.
  • Monashee Investment Management's ten largest holdings make up 67% of its $419M portfolio in Q2 2023.
  • Monashee Investment Management opened 53 new positions and closed 24 in Q2 2023.
  • Monashee Investment Management's portfolio value rose 16% quarter-over-quarter to $419M.

Based on Monashee Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.